doxazosin

Generic: doxazosin

Labeler: zydus pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler zydus pharmaceuticals usa inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 4 mg/1

Manufacturer
Zydus Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 68382-785
Product ID 68382-785_92ead971-9de8-4240-b2c7-fc2e9abac7dd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208719
Listing Expiration 2026-12-31
Marketing Start 2017-08-31

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68382785
Hyphenated Format 68382-785

Supplemental Identifiers

RxCUI
197625 197626 197627 197628
UNII
86P6PQK0MU

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA208719 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68382-785-01)
  • 30 TABLET in 1 BOTTLE (68382-785-06)
  • 1000 TABLET in 1 BOTTLE (68382-785-10)
  • 10 BLISTER PACK in 1 CARTON (68382-785-77) / 10 TABLET in 1 BLISTER PACK (68382-785-30)
source: ndc

Packages (4)

Ingredients (1)

doxazosin mesylate (4 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "92ead971-9de8-4240-b2c7-fc2e9abac7dd", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["e4758bf9-b9d4-4268-beb8-0d7e06890895"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68382-785-01)", "package_ndc": "68382-785-01", "marketing_start_date": "20170831"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68382-785-06)", "package_ndc": "68382-785-06", "marketing_start_date": "20170831"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (68382-785-10)", "package_ndc": "68382-785-10", "marketing_start_date": "20170831"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (68382-785-77)  / 10 TABLET in 1 BLISTER PACK (68382-785-30)", "package_ndc": "68382-785-77", "marketing_start_date": "20170831"}], "brand_name": "Doxazosin", "product_id": "68382-785_92ead971-9de8-4240-b2c7-fc2e9abac7dd", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "68382-785", "generic_name": "Doxazosin", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA208719", "marketing_category": "ANDA", "marketing_start_date": "20170831", "listing_expiration_date": "20261231"}